Skip to content

The Norwegian Stroke in the Young Study II

The Norwegian Stroke in the Young Study II

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02762396
Acronym
NOR-SYSII
Enrollment
130
Registered
2016-05-05
Start date
2016-03-01
Completion date
2022-02-28
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke at a Young Age

Keywords

Young ischemic stroke, Risk factors, Causes, Consequences

Brief summary

NOR-SYS II is designed for finding the cause of acute ischemic stroke lesions in Young adults, age 15 to 49 years. Risk factors, arterial wall changes by intima-media thickness and plaques and consequences of stroke are examined by standardized diagnostics.

Detailed description

NOR-SYS II is as far as possible standardized concerning patients' history, ultrasound examination of pre-cerebral and femoral arteries, and standardized examinations performed by speech therapists, occupational therapists and physiotherapists. The ultrasound-protocol for carotid and femoral arteries is the same as previously performed in the NOR-SYS study. The Methods have been published before.

Interventions

None listed

Sponsors

Helsinki University Central Hospital
CollaboratorOTHER
Haukeland University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Documented acute, arterial ischemic stroke * Speaks Norwegian fluently

Exclusion criteria

* Post-traumatic and procedure related stroke * Sinus venous thrombosis, sepsis and endocarditis * Serious co-morbidity, such as advanced cancer with end-of-life stroke. * Patients mentally retarded or with severe psychiatric disease who do not accept the diagnosis and who would need sedation to perform clinical diagnostics.

Design outcomes

Primary

MeasureTime frameDescription
Established atherosclerosisEstablished atherosclerosis will serve as outcome measure for data collected during hospital stay and will be related to risk factors. The data will be presented one year after finishing the 5-years of inclusion of the whole study group.The ultrasound protocol of the NOR-SYS study will be applied for carotid and femoral arteries. In addition angiographies will be done for patients with suspicious arterial disease. The measurements will be done within hospital stay after the acute stroke.

Secondary

MeasureTime frameDescription
New cardiovascular eventsOne year after the strokePatients With different causes of ischemic stroke have different prognosis that is worst for recurrent stroke and other cardiovascular events for patients with atherosclerosis.
DeathOne year after the strokeDeath fro all causes with subgroups of cardiovascular death, cancer and other causes of death will be registered
Alive but not back to previous education or full-time jobOne year after the strokeNot back to work because of stroke related problems. Standardized questionnaires will be used to collect information about education and work before stroke and the situation after 3 months and one year. The frequency and reasons why patients did not come back to their education situation or their job they did before the stroke are collected. We expect that it is still possible within a year from stroke onset, to specify the sort of problem related to stroke or unrelated to stroke. This may get more unspecific, the longer the time gets from stroke onset to follow-up. NOR-SYS II will focus on a particular group of patients that seem to function well but that struggle with unvisible problems such as tiredness and reduced capacity / energy to work.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026